Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences The Space Summit 2019

Eugene Boland's Biography

Eugene Boland, Chief Scientist, Techshot, Inc.

Eugene Boland, Ph.D., has over 25 years in laboratory research, with a specific focus on developing engineering solutions for cardiovascular diseases as well as chronic wounds. His materials expertise extends from bioinert metals and ceramics to bioactive and bioresorbable electrospun polymers and proteins. After receiving his Bachelor of Science in Biomedical Engineering from Marquette University in 1994, Dr. Boland went on to receive his Ph.D. in Biomedical Engineering from Virginia Commonwealth University in 2004 after six years in the cardiovascular medical device field.

Dr. Boland has held senior engineering positions with companies such as St. Jude Medical Inc., Cordis (a Johnson & Johnson Co.) and Cryolife before completing his doctorate. More recently he has held the position of principal scientist with Tissue Genesis, Inc., and Chief of Regenerative Medicine at the University of Louisville’s Cardiovascular Innovation Institute before joining Techshot in the role of Chief Scientist in 2013.

Eugene Boland Image

BioFabrication Facility, Tissue Printing on the International Space Station

Monday, 14 October 2019 at 16:00

Add to Calendar ▼2019-10-14 16:00:002019-10-14 17:00:00Europe/LondonBioFabrication Facility, Tissue Printing on the International Space StationThe Space Summit 2019 in Coronado Island, CaliforniaCoronado Island,

Techshot is excited to present initial findings from the maiden flight of its BioFabrication Facility operated aboard the ISS after its launch on the SpaceX CRS-18 mission.  The company is exploiting the sustained microgravity effects on bioinks first characterized on June 14, 2016 when it printed the first neonatal heart ventricle in zero gravity using adult human stem cells aboard a parabolic flight aircraft.  For this first technology demonstration flight aboard the ISS, Techshot printed multiple test structures, as well as structural cardiac tissue.  This muscularized tissue could be placed within a patient’s damaged cardiac tissue and be inosculated into the coronary blood flow and regain muscular tone.  These early demonstrations are the precursor for future microgravity whole organ printing investigations.  This 3D bioprinting capability on the ISS will lead to significant commercial advancements in the healthcare industry, while helping mankind explore beyond low Earth orbit.

Add to Calendar ▼2019-10-14 00:00:002019-10-15 00:00:00Europe/LondonThe Space Summit 2019The Space Summit 2019 in Coronado Island, CaliforniaCoronado Island,